
Keywords: DEE; drug-eluting embolic; FdUrd-C8; 3â²,5â²-dioctanoyl-5-fluoro-2â²-deoxyuridine; HCC; hepatocellular carcinoma; IL; interleukin; LRT; locoregional therapy; MN-16ET; N-[2-(triphenylmethyl)thioethyl]-3-aza-19-ethyloxycarbonyl-3-[2-(triphenylmethyl)thio